October is Breast Cancer Awareness Month 🩷 Here are 5️⃣ facts to know about breast cancer.
OHSU Knight Cancer Institute
@ohsuknight.bsky.social
A leader in cancer research, the OHSU Knight Cancer Institute provides individually-tailored, compassionate care for patients, from diagnosis through survivorship.
Share these with a friend, a family member, or a loved one.
For more information surrounding #BreastCancer, including screening, signs and symptoms, who's at risk, survival rates, and clinical trials ⤵️
OHSU: Nationally Recognized Breast Cancer Care Near You
From second opinions to survivorship support, OHSU's breast cancer specialists guide you at every step, combining clinical excellence with whole-person care.
bit.ly
“When Doc walks in, I don’t have to explain anything. It’s a different way of showing how much you care for another being, and I really appreciate that OHSU recognizes that. He’s just a good boy. And he brings people joy.” - Patient, Angela Allen on therapy dog, Doc:
The ‘Doc’ is in: Assistance dog provides comfort to patients with cancer
‘He’s a good boy. And he brings people joy’: Partnership with Assistance Dogs Northwest expands to Knight Cancer Institute.
news.ohsu.edu
The 'Doc' is in 🐕 Through a partnership with Assistance Dogs Northwest, Doc comforts patients at the OHSU Knight Cancer Institute. Doc joins Casey and Darby to make a special trio of OHSU paw-fessionals dedicated to supporting patients, families, and caregivers:
The ‘Doc' is in: Assistance dog provides comfort to patients with cancer
‘He's a good boy. And he brings people joy': Partnership with Assistance Dogs Northwest expands to Knight Cancer Institute.
news.ohsu.edu
“When we’re designing systems for healthcare, we forget that we’re designing the systems for the patient. The system designs the system for itself, and then we try to adjust it to the patient.” - Dr. Eneida Nemecek at the TIME100 Health Leadership Forum: https://bit.ly/4xWMbFE
Congratulations to @meganburgerphd.bsky.social on receiving a MERIT Award from the National Cancer Institute for her project, “Antigen immunodominance in regulation of anti-tumor CD8 T cell immunity and immunotherapy response.” Learn more ➡️ https://bit.ly/3VjURZ1
"I see PSI as a way to pay forward the work of the mentors I had in high school and college who were crucial to setting me on the path of becoming a scientist." - Sam King, an M.D., Ph.D. student in the Donald Conrad lab, who volunteers in the PSI program: https://bit.ly/4hCn6tu
“This is a really exciting study that is responsive to the needs of our clinical and patient partners." - Dr. Melinda Davis on receiving funding to help address barriers that prevent patients from getting cancer screenings: https://bit.ly/4ADQqbu
Congratulations to Dr. Melinda Davis on receiving a multi-phase award from the National Cancer Institute to help address barriers that prevent patients across Oregon from getting cancer screenings. Learn more: https://bit.ly/4ADQqbu
High school students spent the summer stepping into biomedical research, working alongside scientists, attending lectures, and gaining hands-on laboratory experience through the OHSU Neuro-Oncology Blood-Brain Barrier Program. Learn more ➡️ https://bit.ly/4hCn6tu
“We screen for just five cancers, yet the ones we can't screen for cause up to 70% of cancer deaths in this country; that’s the gap this blood test helps close.” - Dr. Nima Nabavizadeh
PATHFINDER 2 findings advance multi-cancer early detection blood testing
Blood test helps increase cancer detection 6.5-fold, identifies many cancers lacking routine screening options.
news.ohsu.edu
“One of the surprising findings is that antioxidants aren't always beneficial in the context of cancer.” - Dr. Robert Eil on #OHSUResearch that found tumors can evade the immune system by releasing the antioxidant protein PRDX1 (via @fox12oregon.bsky.social):
New study shows prooxidants may help fight cancer
A new study shows that some prooxidants may be necessary when battling certain tumors and cancers. We are joined by OHSU Doctor and Researcher, Rob Eil.
kptv.com
“One of the surprising findings is that antioxidants aren't always beneficial in the context of cancer.” - Dr. Robert Eil on #OHSUResearch that found tumors can evade the immune system by releasing the antioxidant protein PRDX1 (via @fox12oregon.bsky.social):
New study shows prooxidants may help fight cancer
A new study shows that some prooxidants may be necessary when battling certain tumors and cancers. We are joined by OHSU Doctor and Researcher, Rob Eil.
kptv.com
Today, we announced our inaugural board of directors, uniting leaders from healthcare, Fortune 500 companies, public policy, philanthropy, research, and more to guide the organization’s next phase of growth. Learn more: https://bit.ly/4hqishU
New board of directors signal ambitious momentum for OHSU Knight Cancer Institute
Read More
bit.ly
New findings from the PATHFINDER 2 study show that adding a multi-cancer early detection blood test to recommended #cancer screening increased the number of cancers detected by 6.5 times. https://news.ohsu.edu/2026/09/22/pathfinder-2-findings-advance-multi-cancer-early-detection-blood-testing
“I think we’ve just scratched the surface of what we can do with these ultrasound-responsive biomaterials.” - Dr. Carolyn Schutt Ibsen, whose research focuses on developing ultrasound-responsive liposomes that encapsulate therapeutic materials like DNA. Learn more: https://bit.ly/4yDF6up
“Before I retire, I'd really like to be able to cure it [CML]. You know, take it from well-controlled, taking a pill a day to completely eradicate it.” - Dr. Brian Druker on #WorldCMLDay:
kgw.com
"It's been the honor of my life to fight for my patients and to see Gleevec give hundreds of thousands of people their lives back.” - Dr. Brian Druker reflecting on the 25th anniversary of Gleevec's FDA approval #WorldCMLDay:
news.ohsu.edu
In 1998, Mel Mann was told he had #CML and that he had three years to live. Fast forward to 2026 ⏩ Mel's still healthy and training for his next marathon. 🏃 On this #WorldCMLDay, listen to Mel's story (via @npr.org):
npr.org
“I think we’ve just scratched the surface of what we can do with these ultrasound-responsive biomaterials.” - Dr. Carolyn Schutt Ibsen, whose research focuses on developing ultrasound-responsive liposomes that encapsulate therapeutic materials like DNA. Learn more: https://bit.ly/4yDF6up
“I think we’ve just scratched the surface of what we can do with these ultrasound-responsive biomaterials.” - Dr. Carolyn Schutt Ibsen, whose research focuses on developing ultrasound-responsive liposomes that encapsulate therapeutic materials like DNA. Learn more: https://bit.ly/4yDF6up
“What's exciting is that we've identified a target nobody was really looking for before. Discovering new targets is how future treatments begin.” - Dr. Robert Eil on identifying potential therapeutic targets in tumors that evade the immune system:
Cancer cells use antioxidant protein to suppress T cells, resist immunotherapy, study finds
OHSU co-author helps identify potential therapeutic target in tumors that evade the immune system.
news.ohsu.edu
Starting Sept. 11th, all lanes of I-5 southbound between I-405 and I-84 will be closed for up to five weeks, causing major traffic delays across the Portland area. Patients, students, visitors , and volunteers should plan extra travel time to OHSU. Learn more: https://bit.ly/4x3pD5m
“Every time we uncover a new way tumors suppress the immune system, we gain another opportunity to fight back. That's how better treatments are built.” - Dr. Robert Eil on new #OHSUResearch:
Cancer cells use antioxidant protein to suppress T cells, resist immunotherapy, study finds
OHSU co-author helps identify potential therapeutic target in tumors that evade the immune system.
news.ohsu.edu
“What's exciting is that we've identified a target nobody was really looking for before. Discovering new targets is how future treatments begin.” - Dr. Robert Eil on identifying potential therapeutic targets in tumors that evade the immune system:
Cancer cells use antioxidant protein to suppress T cells, resist immunotherapy, study finds
OHSU co-author helps identify potential therapeutic target in tumors that evade the immune system.
news.ohsu.edu
Starting Sept. 11th, all lanes of I-5 southbound between I-405 and I-84 will be closed for up to five weeks, causing major traffic delays across the Portland area. Patients, students, visitors , and volunteers should plan extra travel time to OHSU. Learn more: https://bit.ly/4x3pD5m
Starting Sept. 11th, all lanes of I-5 southbound between I-405 and I-84 will be closed for up to five weeks, causing major traffic delays across the Portland area. Patients, students, visitors , and volunteers should plan extra travel time to OHSU. Learn more: https://bit.ly/4x3pD5m
“Every time we uncover a new way tumors suppress the immune system, we gain another opportunity to fight back. That's how better treatments are built.” - Dr. Robert Eil on new #OHSUResearch:
Cancer cells use antioxidant protein to suppress T cells, resist immunotherapy, study finds
OHSU co-author helps identify potential therapeutic target in tumors that evade the immune system.
news.ohsu.edu
Congratulations to Dr. Shannon McWeeney on earning the Walter and Clora Brownfield Endowed Professorship in Cancer Research! As Chief Data Officer, Dr. McWeeney develops rigorous computational methods that support precision decision-making at the point of care for cancer patients.
